Stock And Mixed Assets ETFs Attract Record Net Inflows In December While Mutual Funds See Redemptions
https://seekingalpha.com/article/4663622-stock-and-mixed-assets-etfs-attract-record-net-inflows-in-december?source=feed_tag_etf_portfolio_strategy
Jan 18, 2024 - Mutual fund investors withdrew $86.0 billion in December, while money market funds saw net inflows. Click here to read our most recent report.
0
A New Way to See Your Climate Anxiety
https://www.wired.com/story/a-new-way-to-see-your-climate-anxiety/
Jan 22, 2024 - The climate crisis has become a mental health crisis. But eco-anxiety isn’t necessarily a pathology.
0
Tesla Earnings: 6 Key Metrics You Should See
https://www.fool.com/investing/2024/01/24/tsla-stock-q4-earnings-revenue-earnings-miss/?source=iedfolrf0000001
Jan 24, 2024 - Tesla stock tanked in Wednesday's after-hours trading after the release of the company's latest earnings report.
0
UBS cuts Cytokinetics to neutral, sees takeout valuation at $105
https://seekingalpha.com/news/4057887-ubs-cuts-cytokinetics-to-neutral-sees-takeout-valuation-at-105?source=feed_sector_healthcare
Jan 24, 2024 - UBS has downgraded Cytokinetics (CYTK) to neutral, commenting that it believes some of the potential M&A premium has already been baked into the stock’s price. Read more here.
0
BMO start Sarepta at overweight, sees significant uptake for Elevidys
https://seekingalpha.com/news/4060874-bmo-start-sarepta-at-overweight-sees-significant-uptake-for-elevidys?source=feed_sector_healthcare
Jan 31, 2024 - BMO has initiated coverage of Sarepta Therapeutics (SRPT) with a outperform rating, citing its leading position in the Duchenne muscular dystrophy market. Read more here.
0
U.S. Stocks May See Initial Weakness On Disappointing Tech Earnings News
https://www.rttnews.com/story.aspx?Id=3420704
Jan 31, 2024 - Following the mixed performance seen in the previous session, stocks may move to the downside in early trading on Wednesday. Technology stocks may extend the notable pullback seen in the previous session, as reflected by the 1.0 percent slump by the Nasdaq 100 futures. A steep drop by shares of Alphabet is likely to weigh on the tech sector.
0
Hubbell Incorporated: Rating Upgrade As FY24 Guidance Could See A Beat
https://seekingalpha.com/article/4667264-hubbel-incorporated-rating-upgrade-as-fy24-guidance-could-see-beat?source=feed_all_articles
Feb 02, 2024 - HUBB reported strong results for Q4 2023, with sales growing 10% and segment profit growing 34%. Read more about HUBB stock here.
0
McDonald's is promising its 'Best Burger.' Now the chain will see if diners buy more of them
https://www.cnbc.com/2024/02/04/mcdonalds-launches-best-burger-ahead-of-earnings-report.html
Feb 05, 2024 - McDonald's restaurants in the U.S. are now serving improved versions of the chain's famous burgers, and the company hopes the move will unlock sales growth.
0
U.S. Stocks May See Further Upside In Early Trading
https://www.rttnews.com/story.aspx?Id=3423607
Feb 09, 2024 - The major U.S. index futures are currently pointing to a higher open on Friday, with stocks likely to add to the modest gains seen at the close of yesterday's lackluster session.
0
Lyft sees full year free cash flow positivity, CEO says drivers "huge area of focus" (update)
https://seekingalpha.com/news/4066452-lyft-sees-full-year-free-cash-flow-positivity-for-first-time-stock-rockets-after-hours?utm_source=feed_news_all&utm_medium=referral&feed_item_type=news
Feb 13, 2024 - Lyft (LYFT) on Tuesday said it would generate positive free cash flow for a full year for the first time. Read more here.
0